Table 1.
The distribution of histologic alterations within the groups
| Group 1 (n/%) | Group 2 (n/%) | P | Kappa | |
|---|---|---|---|---|
| Acute cholecystitis |
31 (7.2%) |
31 (7.2%) |
>0.05 |
0.965 |
| Chronic cholecystitis |
401 (92.8%) |
401 (92.8%) |
|
|
| Non-cholesterolosis |
337 (78%) |
324 (75%) |
0.001 |
0.904 |
| Cholesterolosis |
95 (22%) |
108 (25%) |
|
|
| Non-metaplasia |
407 (94.2%) |
391 (91.2%) |
0.0001 |
0.739 |
| Pyloric metaplasia |
23 (5.3%) |
38 (8.8%) |
|
|
| Intestinal metaplasia |
2 (0.5%) |
3 (0.7%) |
|
|
| Non-polyp |
422 (97.8%) |
416 (96.6%) |
0.031 |
0.76 |
| Cholesterol polyp |
7 (1.6%) |
11 (2.5%) |
|
|
| Fibroepithelial polyp |
1 (0.2%) |
2 (0.5%) |
|
|
| Tubular adenoma |
1 (0.2%) |
1 (0.2%) |
|
|
| Papillary adenoma |
1 (0.2%) |
1 (0.2%) |
|
|
| Non-dysplasia |
430 (99.5%) |
430 (99.5%) |
>0.05 |
1.0 |
| Low grade dysplasia |
2 (0.5%) |
2 (0.5%) |
|
|
| High grade dysplasia |
0 (0%) |
0 (0%) |
|
|
| Carcinoma | 0 (0%) | 0 (0%) | >0.05 | 1.0 |